Haematological effects of interferon-beta-1a (Rebif) therapy in multiple sclerosis.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Works matching IS 01145916 AND DT 2004 AND VI 27 AND IP 10
Results: 8
1
2
Safety related drug-labelling changes: findings from two data mining algorithms.
- Published in:
- 2004
- By:
- Publication type:
- journal article
3
A Benefit-Risk Assessment of Inhaled Long-Acting β<sub>2</sub>-Agonists in the Management of Obstructive Pulmonary Disease.
- Published in:
- Drug Safety, 2004, v. 27, n. 10, p. 689, doi. 10.2165/00002018-200427100-00001
- By:
- Publication type:
- Article
4
Safety Related Drug-Labelling Changes.
- Published in:
- Drug Safety, 2004, v. 27, n. 10, p. 735, doi. 10.2165/00002018-200427100-00004
- By:
- Publication type:
- Article
5
Calculation of Doses of Drugs in Solution.
- Published in:
- Drug Safety, 2004, v. 27, n. 10, p. 729, doi. 10.2165/00002018-200427100-00003
- By:
- Publication type:
- Article
6
Comparative tolerability of drug treatment for nocturnal enuresis in children.
- Published in:
- 2004
- By:
- Publication type:
- journal article
7
Calculation of doses of drugs in solution: are medical students confused by different means of expressing drug concentrations?
- Published in:
- 2004
- By:
- Publication type:
- journal article
8
Haematological Effects of Interferon-β-1a (Rebif®) Therapy in Multiple Sclerosis.
- Published in:
- Drug Safety, 2004, v. 27, n. 10, p. 745, doi. 10.2165/00002018-200427100-00005
- By:
- Publication type:
- Article